AJICAP-M: Traceless Affinity Peptide Mediated Conjugation Technology for Site-Selective Antibody–Drug Conjugate Synthesis
Organic Letters · 12.07.2024 · 26 (27) · 5597-5601
DOI: 10.1021/acs.orglett.4c00878 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic Letters, online erschienen am 19.04.2024. Verfasst von Yutaka Matsuda und 13 weiteren Autor:innen. Beteiligte Einrichtung: Ajinomoto Co., Inc., 1-1, Suzuki-Cho, Kawasaki-Ku, Kawasaki-Shi, Kanagawa 210-8681, Japan. Hauptthemen laut MEDLINE: Immunoconjugates, Peptides. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Ajinomoto Co., Inc., 1-1, Suzuki-Cho, Kawasaki-Ku, Kawasaki-Shi, Kanagawa 210-8681, Japan.
- Ajinomoto Bio-Pharma Services, 11040 Roselle Street, San Diego, California 92121, United States.
ORCID-Profile: Yutaka Matsuda, Yuichi Nakahara, Kazutoshi Takahashi, Brian A Mendelsohn, Shigeo Hirasawa
Zitieren
APA
Matsuda, Y., Shikida, N., Hatada, N., Yamada, K., Seki, T., Nakahara, Y., Endo, Y., Shimbo, K., Takahashi, K., Nakayama, A., Mendelsohn, B. A., Fujii, T., Okuzumi, T., & Hirasawa, S. (2024). AJICAP-M: Traceless Affinity Peptide Mediated Conjugation Technology for Site-Selective Antibody–Drug Conjugate Synthesis. Organic Letters, 26(27), 5597-5601. https://doi.org/10.1021/acs.orglett.4c00878
Vancouver
Matsuda Y, Shikida N, Hatada N, Yamada K, Seki T, Nakahara Y, et al. AJICAP-M: Traceless Affinity Peptide Mediated Conjugation Technology for Site-Selective Antibody–Drug Conjugate Synthesis. Organic Letters. 2024;26(27):5597-5601. doi:10.1021/acs.orglett.4c00878
BibTeX
@article{Matsuda2024,
author = {Matsuda, Yutaka and Shikida, Natsuki and Hatada, Noriko and Yamada, Kei and Seki, Takuya and Nakahara, Yuichi and Endo, Yuta and Shimbo, Kazutaka and Takahashi, Kazutoshi and Nakayama, Akira and Mendelsohn, Brian A and Fujii, Tomohiro and Okuzumi, Tatsuya and Hirasawa, Shigeo},
title = {AJICAP-M: Traceless Affinity Peptide Mediated Conjugation Technology for Site-Selective Antibody–Drug Conjugate Synthesis},
journal = {Organic Letters},
year = {2024},
volume = {26},
number = {27},
pages = {5597--5601},
doi = {10.1021/acs.orglett.4c00878}
}
EUVIMED